Global Labyrinthitis Market Size, Share, Forecast Report, 2020-2027

Labyrinthitis, also known as vestibular neuritis, is an inflammation of the inner ear or the nerves that connect the inner ear to the brain due to a variety of reasons such as infection by measles, mumps, trauma, autoimmune etc. Labyrinthitis shows various symptoms such as hearing loss, speech problems, double vision, abnormal gait, dizziness, nystagmus (rapid and undesired eye motion), vertigo, ringing in the ears, etc. Labyrinthitis is triggered by cold flu and occur as a single attack, or a series of attacks, which generally resolves on its own over three to six weeks.

The causes of labyrinthitis are upper respiratory infection such as common cold or flu, infection by herpes simplex type 1 virus, acute localized ischemia, pressure changes such as while flying or scuba diving, etc. Labyrinthitis affects approximately 35 cases per 1 million people per year across the globe and it is rising due to growing exposure to pathogenic agents. Labyrinthitis affects older population to a greater degree due to weak immunity and hearing problems.

Rising older population, increasing awareness and screening, developing healthcare and ENT centres, developing new drugs, especially the advancements in antibiotics are driving the market growth. Development of selective antibiotics for ear and nose infections such as streptomycin has driven the market growth. On the other hand, side effects and high cost of treatment and misdiagnosis may hinder the growth of the labyrinthitis market over the review period.

The global labyrinthitis market is expected to reach USD 2.5 billion by 2023 at a CAGR of ~ 3.2% during the forecast period 2017-2023.
Segments

The global labyrinthitis market has been segmented on the basis of types, diagnosis, treatment, and end user.

Based on the types, the market has been segmented as autoimmune labyrinthitis, infective labyrinthitis, and other.

Based on the diagnosis, the market has been segmented as physical examination, blood test, magnetic resonance imaging and computed tomography, electroencephalogram (EEG) and electronystagmography (ENG) and others.

Based on the treatment, the market has been segmented as antihistaminics and antiemetics, antibiotics, corticosteroids, and others.

Based on the end user, the market has been segmented as hospitals & clinics, academic and research, and others.
Key Players in the Global Labyrinthitis Market

Some of the key players profiled in the report are Merck & Co., Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Mylan N.V., Eli Lilly and Company, Sun Pharmaceutical Industries Ltd., Shandong Taihua Bio &Tech Co., Cipla Inc., and others.